glp 1 and stomach issues GLP-1 Medications: Understanding How to Manage Side Effects Glp 1 Mechanism Infographic

( GLP-1 RAs recently appearing on the market, in particular liraglutide, semaglutide and tirzepatide (a GIP/GLP-1 RA dual agonist) seek to overcome the problem of the short plasma half-life of native GLP-1 through (i) changing the amino acid sequence of the peptide so that it is no longer broken down by DPP-4, and/or (ii) attaching a long acyl chain to the peptide, thus allowing it to bind to albumin, and avoid rapid elimination via the kidney

In: Plewig, G., French, L., Ruzicka, T., Kaufmann, R., Hertl, M

Their role extends far beyond flavour

Its a type of injectable medication called a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist

Some people also use it for chronic pain in joints, tendons, and inflammatory conditions